SPDR SP Ownership
| XBI Etf | USD 82.27 0.11 0.13% |
SPDR Etf Ownership Analysis
SPDR SP is is formed as Regulated Investment Company in the United States. ETF is managed and operated by SSgA Funds Management, Inc.. The fund has 157 constituents with avarage daily trading value of 10.7 M. The fund charges 0.35 percent management fee with a total expences of 0.35 percent of total asset. The fund keeps 99.97% of net assets in stocks. SPDR SP Biotech last dividend was 0.017 per share. In seeking to track the performance of the SP Biotechnology Select Industry Index , the fund employs a sampling strategy. SP Biotech is traded on NYSEARCA Exchange in the United States. For more information please call the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on SPDR Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding SPDR SP , and the less return is expected.
Investment Allocations (%)
Top Etf Constituents
| OCGN | Ocugen Inc | Stock | |
| SGMO | Sangamo Therapeutics | Stock | |
| BPMC | Blueprint Medicines Corp | Stock | |
| SRPT | Sarepta Therapeutics | Stock | |
| LGND | Ligand Pharmaceuticals Incorporated | Stock | |
| VRTX | Vertex Pharmaceuticals | Stock | |
| ARWR | Arrowhead Pharmaceuticals | Stock | |
| PBYI | Puma Biotechnology | Stock | |
| ANAB | AnaptysBio | Stock | |
| NTLA | Intellia Therapeutics | Stock | |
| TGTX | TG Therapeutics | Stock | |
| FOLD | Amicus Therapeutics | Stock | |
| HRTX | Heron Therapeuti | Stock | |
| ALNY | Alnylam Pharmaceuticals | Stock | |
| BBIO | BridgeBio Pharma | Stock | |
| NTRA | Natera Inc | Stock | |
| EXEL | Exelixis | Stock | |
| INO | Inovio Pharmaceuticals | Stock | |
| BCRX | BioCryst Pharmaceuticals | Stock | |
| ARCT | Arcturus Therapeutics Holdings | Stock | |
| MRNA | Moderna | Stock | |
| REGN | Regeneron Pharmaceuticals | Stock |
Institutional Etf Holders for SPDR SP
| DMSZX | Destinations Multi Strategy | Mutual Fund | |
| BUYW | Main Buywrite ETF | Etf | |
| DMSFX | Destinations Multi Strategy | Mutual Fund | |
| DEVDX | Driehaus Event Driven | Mutual Fund | |
| PAPPX | Papp Small Mid Cap | Mutual Fund | |
| TCMSX | Tcm Small Cap | Mutual Fund | |
| CAPTX | Canterbury Portfolio Thermostat | Mutual Fund | |
| FIMPX | Nuveen Small Cap | Mutual Fund | |
| FRMPX | Nuveen Small Cap | Mutual Fund | |
| FMPFX | Nuveen Small Cap | Mutual Fund | |
| ETFCX | Stadion Tactical Growth | Mutual Fund | |
| ETFAX | Stadion Tactical Growth | Mutual Fund | |
| ETFOX | Stadion Tactical Growth | Mutual Fund | |
| SECT | Main Sector Rotation | Etf | |
| TSCGX | Thrivent Small Cap | Mutual Fund | |
| HHCAX | Highland Longshort Healthcare | Mutual Fund | |
| HHCCX | Highland Longshort Healthcare | Mutual Fund | |
| HHCZX | Highland Longshort Healthcare | Mutual Fund | |
| LABU | Direxion Daily SP | Etf |
SPDR SP Outstanding Bonds
SPDR SP issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SPDR SP Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SPDR bonds can be classified according to their maturity, which is the date when SPDR SP Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US7846ELAD98 Corp BondUS7846ELAD98 | View | |
| SSC Technologies 55 Corp BondUS78466CAC01 | View | |
| US7846ELAE71 Corp BondUS7846ELAE71 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Currently Active Assets on Macroaxis
| ISPY | ProShares SP 500 | |
| SPYI | SHP ETF Trust | |
| QYLD | Global X NASDAQ | |
| MET1 | Metals One PLC | |
| MSFT | Microsoft |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Biotech. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
The market value of SPDR SP Biotech is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.